As of May 24, 2025, Embecta Corp (EMBC) reports a Gross Margin of 65.46%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Embecta Corp's Gross Margin
Over recent years, Embecta Corp's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-09-30 | 65.46% |
| 2023-09-30 | 66.91% |
| 2022-09-30 | 68.61% |
| 2021-09-30 | 68.67% |
| 2020-09-30 | 70.26% |
This gradual decrease highlights how Embecta Corp manages its operational efficiency and pricing power over time.
Comparing Embecta Corp's Gross Margin to Peers
To better understand Embecta Corp's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Embecta Corp (EMBC) | 65.46% |
| STAAR Surgical Co (STAA) | 76.32% |
| Align Technology Inc (ALGN) | 70.00% |
| Cooper Companies Inc (COO) | 66.64% |
| Lantheus Holdings Inc (LNTH) | 64.43% |
| Haemonetics Corp (HAE) | 54.13% |
Compared to its competitors, Embecta Corp's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.